X

Trial Profile

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 01 Nov 2009

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Perindopril/indapamide (Primary) ; Gliclazide
Indications Diabetic angiopathies; Diabetic complications; Diabetic retinopathy; Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms AdRem; ADVANCE

Most Recent Events

01 Oct 2009 Status changed from not stated to completed based on publication of results in Diabetologia.
01 Oct 2009 Results were published in Diabetologia.
29 Nov 2006 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com